Jubitrex 500 mg and 1 000 mg FC tablet.
PDF Leaflet Revision Date: 20 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of herpes zoster and recurrent genital herpes.
Dosage (summary)
Herpes zoster: 1000 mg TID for 7 days; Genital herpes: 500 mg BID for 5 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; contraindicated in breastfeeding.
Key Drug Interactions
- Nephrotoxic agents
- Cimetidine
- Probenecid
Contraindications
- Hypersensitivity to valaciclovir or aciclovir
Common side effects
- Headache
- Nausea
- Dizziness
- Vomiting
Counselling Points
- Avoid intercourse during symptoms
- Ensure adequate hydration
- Monitor for neurological symptoms
Serious warnings
- Risk of DRESS
- Thrombotic thrombocytopenic purpura
Important Disclaimer
The Jubitrex 500 mg and 1 000 mg FC tablet. professional information leaflet below is the property of Jubilant Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
